Nuveen’s Grace Therapeutics GRCE Stock Holding History

Nuveen’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.82K	Buy	+863	New	+$1.92K	﹤0.01%	4870

Other funds holding GRCE

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.75B AUM 16.25% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Nuveen's GRCE Position: Q3 2026 in Review

Nuveen opened a new position in Grace Therapeutics (GRCE) in Q3 2026: 863 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #4870 among its holdings.

9 funds tracked by Wall St. Rank hold GRCE as of Q3 2026.

Nuveen held 863 shares of Grace Therapeutics worth $1.82K as of Q3 2026.
Grace Therapeutics was a new Nuveen position in Q3 2026.
Grace Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4870 holding.
9 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.